Filing Details
- Accession Number:
- 0000899243-20-003354
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-05 17:55:27
- Reporting Period:
- 2020-02-03
- Accepted Time:
- 2020-02-05 17:55:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1701541 | Black Diamond Therapeutics Inc. | BDTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1637054 | Brent Hatzis-Schoch | C/O Black Diamond Therapeutics, Inc. 139 Main Street Cambridge MA 02142 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-03 | 3,000 | $19.00 | 3,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On February 3, 2020, Reporting Person purchased 3,000 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.
Billionaire Hedge Funds
